proton planning cover

Philips and Masimo
Partnering to deliver the future of continuous monitoring

Philips has teamed up with Masimo to expand the clinical capabilities of our patient monitoring solutions. Sensor and signal processing technologies are an essential component of patient monitoring solutions, and Masimo is a prolific innovator in this field. Masimo SET® is estimated to be used in over 100 million patients in hospitals worldwide. And Masimo's rainbow SET™ – available on Philips monitors – is a clinically proven platform for non-invasive and continuous haemoglobin monitoring.1

masthead banner image

In their words

CEOs of Philips and Masimo discuss the exciting new partnership

Continuous monitoring,

advanced capabilities

– across patient acuity levels

As a leader in patient monitoring solutions with a primary focus on early detection and prevention of patient deterioration, Philips supports clinical workflow and caregiver efficiencies and enhanced patient care. Our monitors are ideal for acute care settings such as the OR or A&E. Designed to simplify access to patient information, our monitors deliver contextual and clinically relevant information to the bedside and during transport.

 

Now integrated with Masimo technology, our patient monitoring solution delivers the innovative capabilities of Philips lntelliVue with the advanced visibility of non-invasive, continuous haemoglobin measurements.

Monitor family

Informed care every step of the way

 

A patient care journey

The intelliVue X3 transforms from a multi-measurement bedside module into a rugged transport monitor – now serving up a continuous stream of patient vitals and advanced clinical measurements including non-invasive SpHb2 and PVi.

Masimo animation

Learn about our clinical capabilities

See more about Philips and Masimo

Philips and Rainbow SET

Philips IntelliVue with rainbow SET

 

Versatile platform provides continuous and non-invasive patient monitoring with leading haemoglobin measurement technology.

Rainbow SET Technology

rainbow SET measurement technology


Continuous visibility of key patient measurement parameters.

References

 

(1) All studies available at www.masimo.com/evidence/featured-studies/feature/

(2) SpHb monitoring is not intended to replace lab testing. Blood samples should be analyzed by lab instruments prior to clinical decision making. 

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.